Cargando…
Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer
Circulating tumor DNA (ctDNA) in peripheral blood has been used to predict prognosis and therapeutic response for triple-negative breast cancer (TNBC) patients. However, previous approaches typically use large comprehensive panels of genes commonly mutated across all breast cancers. Given the reduct...
Autores principales: | Barnell, Erica K., Fisk, Bryan, Skidmore, Zachary L., Cotto, Kelsy C., Basu, Anamika, Anand, Aparna, Richters, Megan M., Luo, Jingqin, Fronick, Catrina, Anurag, Meenakshi, Fulton, Robert, Ellis, Matthew J., Griffith, Obi L., Griffith, Malachi, Ademuyiwa, Foluso O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588015/ https://www.ncbi.nlm.nih.gov/pubmed/36273232 http://dx.doi.org/10.1038/s41598-022-20928-8 |
Ejemplares similares
-
In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines
por: James, C. Alston, et al.
Publicado: (2021) -
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer
por: Freshour, Sharon L., et al.
Publicado: (2023) -
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer
por: Freshour, Sharon L., et al.
Publicado: (2023) -
CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase
por: Wagner, Alex H., et al.
Publicado: (2020) -
ORegAnno 3.0: a community-driven resource for curated regulatory annotation
por: Lesurf, Robert, et al.
Publicado: (2016)